Given this finding of Fgl2 production by exhausted PD-1+ CD8+ T cells in both humans and mice with cancer, we next sought to determine the association of CD8+ T cell-expressed Fgl2 with patient outcomes in melanoma. The gene discussed is CD8A; the disease is cancer.